Showing results (61-70 of 158) with videos related to
Sort By:
Pageof 16
Neurochemistry International|September 24, 2004
Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladderH Henry Lai, Timothy B Boone, Guang Yang, et al.Cancer Research|January 11, 2013
Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancerSalahaldin A Tahir, Guang Yang, Alexei Goltsov, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2007
Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapyYasutomo Nasu, Takashi Saika, Shin Ebara, et al.Future Oncology (London, England)|April 1, 2025
Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patientsRana R McKay, Ashley E Ross, Mark A Preston, et al.Current Treatment Options in Oncology|January 11, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.Cancer|February 25, 2003
Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patientsTakefumi Satoh, Guang Yang, Shin Egawa, et al.The Prostate|March 9, 2010
Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomesWendy J Langeberg, Salahaldin A Tahir, Ziding Feng, et al.Human Pathology|June 29, 2007
Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancerRile Li, Sibel Erdamar, Hong Dai, et al.American Journal of Cancer Research|April 1, 2021
Genome-wide DNA methylation profiling of leukocytes identifies CpG methylation signatures of aggressive prostate cancerYuyan Han, Mutian Zhang, Junfeng Xu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survivalGuang Yang, Gustavo Ayala, Angelo De Marzo, et al.Pageof 16